GSS EU Science Funding Gateway

Projects will incorporate data on as many of the material properties as possible, allowing for the development of standardised protocols for the determination and measurement of the efficacy and safety of new biomaterials, taking into account the specificities due to sex, race and age, whether they be single or combination entities. A label of biocompatibility should be established so as to define the suitability of a biomaterial for eventual use in a Medical Device or Advanced Therapy that the biomaterial becomes a part of, so as to assist companies, especially SMEs, in choosing and facilitating market access for their products.

Proposals must also address all the areas below:

• Develop a user-friendly platform for making all relevant data easily and readily accessible for the assessment and decision-making processes in appropriate formats to ensure interoperability. To ensure that the data are processed in accordance with the GDPR provisions;
• Facilitate extracting, analysing and re-using of the data with advanced data processing technologies e.g. Artificial Intelligence;
• Provide innovative trainings and manuals for the use of the database and its documentation;
• Develop a business model for the maintenance of the database demonstrating its sustainability beyond the funding period. A contribution of SSH expertise in the field of economics and marketing would be beneficial for the achievement of this goal.